Evidence map›Paper›PMID 18460019›Full record

ArticleClinical and experimental immunology2008

CD26 expression on CD4+T cells in patients with cutaneous leishmaniasis.

R Jafari-Shakib, S Ajdary, Z Mohtasham Amiri, A M Mohammadi, K Nourijelyani, H Mortazavi, M A Shokrgozar, B Nikbin, A Khamesipour

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

R Jafari-ShakibNational Cell Bank of Iran, Pasteur Institute, Tehran, Iran.
S Ajdary
Z Mohtasham Amiri
A M Mohammadi
K Nourijelyani
H Mortazavi
M A Shokrgozar
B Nikbin
A Khamesipour
Faculty of Public Health · GBGuilan University of Medical Sciences · IRInstitut Pasteur · FRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surrogate marker(s) of protection in human leishmaniasis is not well defined. In this study, T helper 1 (Th1) and Th2 cytokine profiles and CD26 expression on CD4(+) T cells in peripheral blood mononuclear cells of patients with healing or non-healing forms of cutaneous leishmaniasis (CL) stimulated with Leishmania antigens were assessed. The level of interferon (IFN)-gamma production was significantly higher in patients with healing or non-healing forms of CL than in healthy controls, but it was not significantly different between the two patient groups. The level of interleukin-5 production was significantly higher in patients with the non-healing form of CL than in the two other groups. There was a significant increase in the level of CD26 expression on CD4(+) T cells in patients with healing (P < 0.001) or non-healing (P = 0.025) forms of CL compared with the control group, but no significant difference was seen between the two patient groups. A weak positive correlation was seen between IFN-gamma production and CD26 expression on CD4(+) T cells of patients with the healing form of lesion (r = 0.54, P = 0.008), but this correlation was not observed in patients with the non-healing form of CL (r = 0.53, P = 0.078). Surface CD26 is not correlated with the clinical manifestation of CL or IFN-gamma production. Therefore, CD26 is not a surrogate marker for IFN-gamma production in CL.

Indexed as

AdultAnimalsAntigens, ProtozoanCase-Control StudiesCD4-Positive T-LymphocytesCell ProliferationDipeptidyl Peptidase 4FemaleFlow CytometryHumansImmunophenotypingInterferon-gammaInterleukin-10Interleukin-5Leishmania majorLeishmaniasis, CutaneousAntigens, ProtozoanDipeptidyl Peptidase 4Interferon-gammaInterleukin-10Interleukin-5

Identifiers

PMID18460019
PMCPMC2432094
OpenAlexW2004863111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.